SciSparc says Neurothera Labs agrees to acquire majority stake in CliniQuantum

robot
摘要生成中

NeuroThera Labs, which is majority-owned by SciSparc (SPRC), has entered into an agreement to acquire approximately 54.01% of CliniQuantum (CliniQ). CliniQ is a quantum technology company focused on developing a next-generation platform for clinical trials using quantum computing. The acquisition involves NeuroThera issuing common shares valued at approximately $9.46 million to CliniQ’s selling shareholders, with potential earn-out payments up to an additional $2.5 million based on specific milestones.

此頁面可能包含第三方內容,僅供參考(非陳述或保證),不應被視為 Gate 認可其觀點表述,也不得被視為財務或專業建議。詳見聲明
  • 讚賞
  • 留言
  • 轉發
  • 分享
留言
請輸入留言內容
請輸入留言內容
暫無留言